Intuitive Surgical (ISRG) Cash & Equivalents (2009 - 2026)

Intuitive Surgical's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $2.8 billion for Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 19.91% year-over-year to $2.8 billion in Q2 2026; TTM through Jun 2026 was $2.8 billion, a 19.91% decrease from a year earlier, with the FY2025 full-year figure at $3.4 billion, up 63.3% from the prior year.
• Cash & Equivalents climbed to $2.8 billion in Q2 2026 per ISRG's latest filing, from $2.0 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $3.6 billion in Q3 2023 and bottomed at $1.1 billion in Q1 2022.
• The 5-year median for Cash & Equivalents is $2.7 billion (2025), against an average of $2.5 billion.
• Across the five-year window, Cash & Equivalents surged 134.2% in 2023 and sank 32.08% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $1.6 billion in 2022, then soared by 75.19% to $2.8 billion in 2023, then retreated by 25.55% to $2.1 billion in 2024, then jumped by 63.3% to $3.4 billion in 2025, then declined by 18.04% to $2.8 billion in 2026.
• Per Business Quant, the three latest ISRG Cash & Equivalents figures stand at $2.8 billion (Q2 2026), $2.0 billion (Q1 2026), and $3.4 billion (Q4 2025).